10x Genomics, Inc.
Key Metrics
- Previous Close
- $56.30
- 52-Week Range
- $15.18 – $102.81
- Market Cap
- $7.51B
- P/E (TTM)
- —
- EPS (TTM)
- -0.52
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 8.95
- PEG Ratio
- —
- Return on Equity
- -8.27%
- Return on Assets
- -3.93%
- Gross Margin
- 71.96%
- Operating Margin
- -10.62%
- Profit Margin
- -10.84%
- Current Ratio
- 5.12
- Debt/Equity
- 0.09
- Total Debt
- $75.79M
- Free Cash Flow
- $122.82M
- Revenue Growth
- 1.10%
- Earnings Growth
- —
- Enterprise Value
- $7.01B
Market Snapshot
About
10x Genomics develops and manufactures gene sequencing and cell analysis technologies for biological research. The company provides integrated solutions for single-cell analysis, spatial genomics, and in situ analysis, enabling researchers to study complex biological systems at unprecedented resolution.